By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Veracyte, Inc. 

6000 Shoreline Court

South San Francisco  California  94080  U.S.A.
Phone: 650-243-6300 Fax: 650-243-6301



Company News
Veracyte (VCYT) Releases Preliminary Third Quarter 2016 Financial Results 10/18/2016 11:12:33 AM
Data Demonstrating Clinical Value Of Veracyte Veracyte (VCYT) Genomic Tests For Use In Lung Cancer And IPF To Be Presented At CHEST Annual Meeting 2016 10/13/2016 6:50:23 AM
Veracyte (VCYT) Releases Statement On CMS's Final 2017 Gapfill Rate For The Afirma Gene Expression Classifier 10/3/2016 8:34:16 AM
Veracyte (VCYT) Presents Data Demonstrating Potential To Enhance Afirma Gene Expression Classifier Using An RNA Sequencing Platform 9/26/2016 8:20:30 AM
Veracyte (VCYT) Secures Draft Medicare Local Coverage Determination For Percepta Bronchial Genomic Classifier From Palmetto GBA 9/16/2016 11:50:39 AM
Veracyte (VCYT) Announces Data From Seven Afirma Gene Expression Classifier Studies To Be Presented At The 86th Annual Meeting Of The American Thyroid Association 9/15/2016 8:42:56 AM
Veracyte (VCYT) Achieves Major Medicare Coverage Milestone For The Percepta Classifier To Improve Lung Cancer Diagnosis 9/8/2016 9:34:43 AM
Veracyte (VCYT) To Present At Morgan Stanley (MST) Global Healthcare Conference 8/30/2016 11:17:22 AM
Veracyte (VCYT) Announces Second Quarter 2016 Financial Results 8/4/2016 7:43:00 AM
Veracyte (VCYT) To Host Conference Call And Webcast To Discuss Second Quarter 2016 Financial Results On Wednesday, August 3, 2016 7/12/2016 7:53:52 AM